Article

Mantle Cell Lymphoma (MCL): Treatment Landscape and Access to Care

https://www.pharmacytimes.org/on-demand/mantle-cell-lymphoma-mcl-treatment-landscape-and-access-to-care

https://www.pharmacytimes.org/on-demand/mantle-cell-lymphoma-mcl-treatment-landscape-and-access-to-care

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Screenshot of an interview with Nicolas Girard, MD, PhD
Byoung Chul Cho, MD, PhD
Related Content
Neoadjuvant radiotherapy was associated with longer time spent in the hospital and a higher risk of short- and long-term wound complications. | Image credit: cacaroot - stock.adobe.com
September 16th 2025

Radiotherapy Raises Risk of Complications After Limb STS Surgery

Jared Kaltwasser
Managed Care Cast
September 16th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey
The use of miRNA in situ hybridization shows clear subtype-specific miRNAs, which the authors said warrant further investigation. | Image credit: CrazyJuke - stock.adobe.com
September 16th 2025

miRNA Profiling May Unlock SCLC Biomarkers

Jared Kaltwasser
managed care cast logo
September 16th 2025

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Brooke McCormick
FDA | Image credit: Postmodern Studio.jpeg
September 16th 2025

FDA Approves Selumetinib for Children With NF1 and Inoperable Tumors

Pearl Steinzor
Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC
September 16th 2025

Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC

Alana Hippensteele, MA

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo